...The companies will develop PharmaDerm's lead products using PharmaDerm's Dermal Drug Delivery System, which provides topical...
...to purchase up to 49 percent of PharmaDerm's common stock. Upon achieving certain development milestones, PharmaDerm...
...injected but for which transdermal delivery would be preferable. Helix BioPharma Corp. (TSE:HPB), Richmond, B.C. PharmaDerm...

...positive recommendations for Actikerall for the indication (see BioCentury, May 16 & June 13). The PharmaDerm...

...The PharmaDerm division of Nycomed's Nycomed U.S. Inc. subsidiary launched a program in the U.S. to...

...2% clindamycin phosphate vaginal cream for 3 or 7 day treatment of bacterial vaginosis (BV). PharmaDerm...

...percent of PharmaDerm it did not already own for 500,000 shares of HBP common stock. PharmaDerm...
...develops methods for injectionless delivery of large therapeutic molecules. Helix BioPHarma Corp. (TSE:HBP), Aurora, Ontario PharmaDerm...